VSIG-3:VISTA [Biotinylated] Inhibitor Screening Assay Kit

Catalog #
79782
$1,175 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The VSIG-3:VISTA[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of VISTA binding to VSIG-3. This kit comes in a convenient 96-well format, with biotin-labeled VISTA, purified VSIG-3, streptavidin-labeled HRP, and assay buffer for 100 binding reactions. The key to this kit is the high sensitivity of detection of biotin-labeled VISTA by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, VSIG-3 is coated on a 96-well plate. Next, biotinylated VISTA is incubated with VSIG-3 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against VSIG-3:VISTA [Biotinylated]? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
V-­set, immunoglobulin domain containing 3, IgSF11, B7-H5
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Materials Required But Not Supplied

PBS (Phosphate buffered saline)
Luminometer or microplate reader capable of reading chemiluminescence
Adjustable micropipettor and sterile tips

Format
Catalog # Component Amount Storage
79491 VSIG-3, Fc-fusion (IgG1), Avi-Tag 20 µg -80°C Avoid
 
freeze/
thaw cycles
 
71327 B7-H5 Fc fusion, Avi-Tag, Biotin-labeled
(VISTA-biotin)
60 µg -80°C
79311 3x Immuno Buffer 1 50 ml -20°C
79728 Blocking Buffer 50 ml +4°C
79742 Streptavidin-HRP 10 µl +4°C
79670 ELISA ECL Substrate A 6 ml Room Temp
ELISA ECL Substrate B 6 ml Room Temp
79699 96-well white microplate 1 +4°C

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*The initial concentrations of VSIG3 and VISTA-biotin are lot specific and will be on the tubes containing the proteins

UniProt #
VSIG-3: Q5DX21; VISTA: Q9H7M9
Background
V-domain Ig Suppressor of T cell activation (VISTA, or B7-H5) is a type I transmembrane protein that functions as an immune checkpoint. V-Set and Immunoglobulin domain containing 3 (VSIG-3, or IGSF11) is a ligand for VISTA which, when bound on activated T cells, inhibits their proliferation and the production of cytokines and chemokines. VSIG-3 expression is elevated in many cancers, especially glioma and melanoma, so the blockade of the VSIG-3/VISTA pathway represents a promising potential cancer immunotherapy strategy.
References

Wang, J., et al. Immunol. 2019, 156.1: 74-85.
Xu, W., et al. Cell. Mol. Immunol. 2018, 15(5): 438-446.